XPA and colorectal carcinoma: Considering the core position of XPA in NER pathway, we assumed that the down‐regulation of XPA in CRC tissues might arise from the impairment of NER capacity upon colorectal carcinogenesis and the low XPA protein expression, which indicates degraded nuclear expression repair in CRC patients, might help create poor prognosis.